XML 33 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2021
Apr. 30, 2020
Current Assets    
Cash and cash equivalents $ 5,206 $ 4,365
Restricted cash 525 850
Receivables, less allowance: $636 (2021); $606 (2020) 34,095 28,062
Inventories 16,517 15,330
Income tax receivable 955 2,717
Prepaid expenses and other current assets 3,159 2,907
Total Current Assets 60,457 54,231
Property, plant and equipment, net 15,982 16,272
Right of use assets 9,279 9,312
Deferred income taxes 0 336
Other assets 3,666 3,778
Total Assets 89,384 83,929
Current Liabilities    
Short-term borrowings 6,828 4,719
Current portion of financing lease liability 21 19
Current portion of operating lease liabilities 1,348 1,282
Accounts payable 16,780 13,114
Employee compensation and amounts withheld 4,726 4,159
Deferred revenue 3,123 2,508
Other accrued expenses 1,355 1,259
Total Current Liabilities 34,181 27,060
Long-term portion of financing lease liability 91 113
Long-term portion of operating lease liabilities 7,860 7,780
Accrued pension and deferred compensation costs 4,652 9,303
Deferred income taxes 307 401
Other non-current liabilities 806 569
Total Liabilities 47,897 45,226
Commitments and Contingencies (Note 8)
Stockholders' Equity    
Common stock 6,915 6,885
Additional paid-in capital 3,807 3,360
Retained earnings 34,149 37,821
Accumulated other comprehensive loss (3,577) (9,598)
Common stock in treasury, at cost: 3 shares (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 41,241 38,415
Non-controlling interest 246 288
Total Stockholders' Equity 41,487 38,703
Total Liabilities and Stockholders' Equity $ 89,384 $ 83,929